Skip Header

You are using a version of browser that may not display all the features of this website. Please consider upgrading your browser.
1 to 25 of 192  Show
  1. 1
    "Cloning and sequence analysis of cDNAs encoding human hippocampus N-methyl-D-aspartate receptor subunits: evidence for alternative RNA splicing."
    Foldes R.L., Rampersad V., Kamboj R.K.
    Gene 131:293-298(1993) [PubMed] [Europe PMC] [Abstract]
    Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), NUCLEOTIDE SEQUENCE [MRNA] OF 11-938 (ISOFORM 3), NUCLEOTIDE SEQUENCE [MRNA] OF 300-938 (ISOFORM 2).
    Category: Sequences.
    Tissue: Brain.
    Source: UniProtKB/Swiss-Prot (reviewed).
  2. 2
    "Molecular cloning and chromosomal localization of the key subunit of the human N-methyl-D-aspartate receptor."
    Karp S.J., Masu M., Eki T., Ozawa K., Nakanishi S.
    J. Biol. Chem. 268:3728-3733(1993) [PubMed] [Europe PMC] [Abstract]
    Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 3).
    Category: Sequences.
    Source: UniProtKB/Swiss-Prot (reviewed).
  3. 3
    "Molecular cloning, functional expression, and pharmacological characterization of an N-methyl-D-aspartate receptor subunit from human brain."
    Planells-Cases R., Sun W., Ferrer-Montiel A.V., Montal M.
    Proc. Natl. Acad. Sci. U.S.A. 90:5057-5061(1993) [PubMed] [Europe PMC] [Abstract]
    Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, SUBCELLULAR LOCATION.
    Category: Function, Subcellular Location, Sequences.
    Tissue: Brain.
    Source: UniProtKB/Swiss-Prot (reviewed).
  4. 4
    "Cloning and structure of the gene encoding the human N-methyl-D-aspartate receptor (NMDAR1)."
    Zimmer M., Fink T.M., Franke Y., Lichter P., Spiess J.
    Gene 159:219-223(1995) [PubMed] [Europe PMC] [Abstract]
    Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA].
    Category: Sequences.
    Source: UniProtKB/Swiss-Prot (reviewed).
  5. 5
    "Cloning and localization of exon 5-containing isoforms of the NMDAR1 subunit in human and rat brains."
    Nash N.R., Heilman C.J., Rees H.D., Levey A.I.
    J. Neurochem. 69:485-493(1997) [PubMed] [Europe PMC] [Abstract]
    Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 6 AND 7), VARIANTS MET-540 AND SER-682.
    Category: Sequences.
    Source: UniProtKB/Swiss-Prot (reviewed).
  6. 6
    "DNA sequence and analysis of human chromosome 9."
    Humphray S.J., Oliver K., Hunt A.R., Plumb R.W., Loveland J.E., Howe K.L., Andrews T.D., Searle S., Hunt S.E., Scott C.E., Jones M.C., Ainscough R., Almeida J.P., Ambrose K.D., Ashwell R.I.S., Babbage A.K., Babbage S., Bagguley C.L.
    Dunham I.
    Nature 429:369-374(2004) [PubMed] [Europe PMC] [Abstract]
    Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
    Category: Sequences.
    Source: UniProtKB/Swiss-Prot (reviewed).

    This publication is cited by 2218 other entries.

  7. 7
    "Cloning and sequence analysis of additional splice variants encoding human N-methyl-D-aspartate receptor (hNR1) subunits."
    Foldes R.L., Rampersad V., Kamboj R.K.
    Gene 147:303-304(1994) [PubMed] [Europe PMC] [Abstract]
    Cited for: NUCLEOTIDE SEQUENCE [MRNA] OF 332-922 (ISOFORM 4), NUCLEOTIDE SEQUENCE [MRNA] OF 86-259 (ISOFORM 5).
    Category: Sequences.
    Tissue: Cerebellum and Hippocampus.
    Source: UniProtKB/Swiss-Prot (reviewed).
  8. 8
    "Inducible expression of neuronal glutamate receptor channels in the NT2 human cell line."
    Younkin D.P., Tang C.-M., Hardy M., Reddy U.R., Shi Q.-Y., Pleasure S.J., Lee V.M.-Y., Pleasure D.
    Proc. Natl. Acad. Sci. U.S.A. 90:2174-2178(1993) [PubMed] [Europe PMC] [Abstract]
    Cited for: NUCLEOTIDE SEQUENCE [MRNA] OF 364-464 (ISOFORMS 1/2/3).
    Category: Sequences.
    Source: UniProtKB/Swiss-Prot (reviewed).
  9. 9
    "Regulation of NMDA receptor phosphorylation by alternative splicing of the C-terminal domain."
    Tingley W.G., Roche K.W., Thompson A.K., Huganir R.L.
    Nature 364:70-73(1993) [PubMed] [Europe PMC] [Abstract]
    Cited for: PHOSPHORYLATION AT SER-889; SER-890; SER-896 AND SER-897 BY PKC.
    Category: PTM / Processing.
    Source: UniProtKB/Swiss-Prot (reviewed).
  10. 10
    "GRINL1A colocalizes with N-methyl D-aspartate receptor NR1 subunit and reduces N-methyl D-aspartate toxicity."
    Roginski R.S., Goubaeva F., Mikami M., Fried-Cassorla E., Nair M.R., Yang J.
    NeuroReport 19:1721-1726(2008) [PubMed] [Europe PMC] [Abstract]
    Cited for: INTERACTION WITH MYZAP.
    Category: Interaction.
    Source: UniProtKB/Swiss-Prot (reviewed).

    This publication is cited by 6 other entries.

  11. 11
    "Synaptonuclear messenger PRR7 inhibits c-Jun ubiquitination and regulates NMDA-mediated excitotoxicity."
    Kravchick D.O., Karpova A., Hrdinka M., Lopez-Rojas J., Iacobas S., Carbonell A.U., Iacobas D.A., Kreutz M.R., Jordan B.A.
    EMBO J. 35:1923-1934(2016) [PubMed] [Europe PMC] [Abstract]
    Cited for: IDENTIFICATION IN A COMPLEX WITH GRIN2B AND PRR7, INTERACTION WITH PRR7.
    Category: Interaction.
    Source: UniProtKB/Swiss-Prot (reviewed).

    This publication is cited by 12 and mapped to 3 other entries.

  12. 12
    "Functional evaluation of a de novo GRIN2A mutation identified in a patient with profound global developmental delay and refractory epilepsy."
    Chen W., Tankovic A., Burger P.B., Kusumoto H., Traynelis S.F., Yuan H.
    Mol. Pharmacol. 91:317-330(2017) [PubMed] [Europe PMC] [Abstract]
    Cited for: FUNCTION, SUBCELLULAR LOCATION, SUBUNIT, MUTAGENESIS OF MET-813.
    Category: Function, Subcellular Location, Pathology & Biotech, Interaction.
    Source: UniProtKB/Swiss-Prot (reviewed).

    This publication is cited by 4 and mapped to 2 other entries.

  13. 13
    "Structures of the M2 channel-lining segments from nicotinic acetylcholine and NMDA receptors by NMR spectroscopy."
    Opella S.J., Marassi F.M., Gesell J.J., Valente A.P., Kim Y., Oblatt-Montal M., Montal M.
    Nat. Struct. Biol. 6:374-379(1999) [PubMed] [Europe PMC] [Abstract]
    Cited for: STRUCTURE BY NMR OF 599-621.
    Category: Structure.
    Source: UniProtKB/Swiss-Prot (reviewed).

    This publication is cited by 2 other entries.

  14. 14
    Cited for: X-RAY CRYSTALLOGRAPHY (2.12 ANGSTROMS) OF 394-544 AND 663-800 IN COMPLEXES WITH GRIN2A AND GLYCINE, FUNCTION, SUBCELLULAR LOCATION, SUBUNIT, DISULFIDE BONDS.
    Category: Function, Subcellular Location, PTM / Processing, Interaction, Structure.
    Source: UniProtKB/Swiss-Prot (reviewed).

    This publication is cited by 2 other entries.

  15. 15
    "Positive Allosteric Modulators of GluN2A-Containing NMDARs with Distinct Modes of Action and Impacts on Circuit Function."
    Hackos D.H., Lupardus P.J., Grand T., Chen Y., Wang T.M., Reynen P., Gustafson A., Wallweber H.J., Volgraf M., Sellers B.D., Schwarz J.B., Paoletti P., Sheng M., Zhou Q., Hanson J.E.
    Neuron 89:983-999(2016) [PubMed] [Europe PMC] [Abstract]
    Cited for: X-RAY CRYSTALLOGRAPHY (1.81 ANGSTROMS) OF 394-544 AND 663-800 IN COMPLEXES WITH GRIN2A AND GLYCINE, FUNCTION, SUBUNIT, SUBCELLULAR LOCATION, DISULFIDE BONDS.
    Category: Function, Subcellular Location, PTM / Processing, Interaction, Structure.
    Source: UniProtKB/Swiss-Prot (reviewed).

    This publication is cited by 4 other entries.

  16. 16
    Cited for: X-RAY CRYSTALLOGRAPHY (2.40 ANGSTROMS) OF 394-544 AND 663-800 IN COMPLEX WITH GRIN2A AND GLYCINE, FUNCTION, SUBCELLULAR LOCATION, SUBUNIT, DISULFIDE BONDS.
    Category: Function, Subcellular Location, PTM / Processing, Interaction, Structure.
    Source: UniProtKB/Swiss-Prot (reviewed).

    This publication is cited by 1 other entry.

  17. 17
    Cited for: VARIANTS NDHMSD SER-560 INS AND LYS-662, CHARACTERIZATION OF VARIANTS NDHMSD SER-560 INS AND LYS-662.
    Category: Pathology & Biotech, Sequences.
    Source: UniProtKB/Swiss-Prot (reviewed).

    This publication is cited by 3 and mapped to 9 other entries.

  18. 18
    Cited for: VARIANTS GLN-306; SER-349 AND ALA-419.
    Category: Sequences.
    Source: UniProtKB/Swiss-Prot (reviewed).

    This publication is cited by 6 and mapped to 13 other entries.

  19. 19
    Category: Pathology & Biotech, Sequences.
    Source: UniProtKB/Swiss-Prot (reviewed).

    This publication is cited by 1 other entry.

  20. 20
    "GRIN1 mutations cause encephalopathy with infantile-onset epilepsy, and hyperkinetic and stereotyped movement disorders."
    Ohba C., Shiina M., Tohyama J., Haginoya K., Lerman-Sagie T., Okamoto N., Blumkin L., Lev D., Mukaida S., Nozaki F., Uematsu M., Onuma A., Kodera H., Nakashima M., Tsurusaki Y., Miyake N., Tanaka F., Kato M.
    Matsumoto N.
    Epilepsia 56:841-848(2015) [PubMed] [Europe PMC] [Abstract]
    Cited for: VARIANTS NDHMSD GLU-552; ILE-641; LYS-650 AND ARG-815.
    Category: Pathology & Biotech, Sequences.
    Source: UniProtKB/Swiss-Prot (reviewed).

    This publication is mapped to 3 other entries.

  21. 21
    "Delineating the GRIN1 phenotypic spectrum: A distinct genetic NMDA receptor encephalopathy."
    Lemke J.R., Geider K., Helbig K.L., Heyne H.O., Schuetz H., Hentschel J., Courage C., Depienne C., Nava C., Heron D., Moeller R.S., Hjalgrim H., Lal D., Neubauer B.A., Nuernberg P., Thiele H., Kurlemann G., Arnold G.L.
    Syrbe S.
    Neurology 86:2171-2178(2016) [PubMed] [Europe PMC] [Abstract]
    Cited for: VARIANTS NDHMSD GLU-552; ARG-557; ARG-618; ARG-620; SER-645; SER-647; ARG-815; VAL-815; LEU-817; ARG-827 AND CYS-844, VARIANTS NDHMSR TRP-217 AND 556-GLN--SER-938 DEL, CHARACTERIZATION OF VARIANTS NDHMSD ARG-557; ARG-618; ARG-620; SER-645; SER-647; ARG-815; LEU-817; ARG-827 AND CYS-844, CHARACTERIZATION OF VARIANTS NDHMSR TRP-217 AND 556-GLN--SER-938 DEL.
    Category: Pathology & Biotech, Sequences.
    Source: UniProtKB/Swiss-Prot (reviewed).

    This publication is mapped to 3 other entries.

  22. 22
    "Novel homozygous missense variant of GRIN1 in two sibs with intellectual disability and autistic features without epilepsy."
    Rossi M., Chatron N., Labalme A., Ville D., Carneiro M., Edery P., des Portes V., Lemke J.R., Sanlaville D., Lesca G.
    Eur. J. Hum. Genet. 25:376-380(2017) [PubMed] [Europe PMC] [Abstract]
    Cited for: VARIANT NDHMSR HIS-227.
    Category: Pathology & Biotech, Sequences.
    Source: UniProtKB/Swiss-Prot (reviewed).

    This publication is mapped to 3 other entries.

  23. 23
    "De novo GRIN1 mutations: An emerging cause of severe early infantile encephalopathy."
    Zehavi Y., Mandel H., Zehavi A., Rashid M.A., Straussberg R., Jabur B., Shaag A., Elpeleg O., Spiegel R.
    Eur. J. Med. Genet. 60:317-320(2017) [PubMed] [Europe PMC] [Abstract]
    Cited for: VARIANTS NDHMSD TYR-688 AND ARG-827.
    Category: Pathology & Biotech, Sequences.
    Source: UniProtKB/Swiss-Prot (reviewed).

    This publication is mapped to 3 other entries.

  24. 24
    "GRIN1 mutation associated with intellectual disability alters NMDA receptor trafficking and function."
    Chen W., Shieh C., Swanger S.A., Tankovic A., Au M., McGuire M., Tagliati M., Graham J.M., Madan-Khetarpal S., Traynelis S.F., Yuan H., Pierson T.M.
    J. Hum. Genet. 62:589-597(2017) [PubMed] [Europe PMC] [Abstract]
    Cited for: VARIANT NDHMSD ARG-620, CHARACTERIZATION OF VARIANT NDHMSD ARG-620.
    Category: Pathology & Biotech, Sequences.
    Source: UniProtKB/Swiss-Prot (reviewed).

    This publication is mapped to 5 other entries.

  25. 25
    "Molecular mechanism of disease-associated mutations in the pre-M1 helix of NMDA receptors and potential rescue pharmacology."
    Ogden K.K., Chen W., Swanger S.A., McDaniel M.J., Fan L.Z., Hu C., Tankovic A., Kusumoto H., Kosobucki G.J., Schulien A.J., Su Z., Pecha J., Bhattacharya S., Petrovski S., Cohen A.E., Aizenman E., Traynelis S.F., Yuan H.
    PLoS Genet. 13:E1006536-E1006536(2017) [PubMed] [Europe PMC] [Abstract]
    Cited for: CHARACTERIZATION OF VARIANT NDHMSD GLU-552 AND ARG-557.
    Category: Pathology & Biotech, Sequences.
    Source: UniProtKB/Swiss-Prot (reviewed).

    This publication is cited by 4 other entries.

1 to 25 of 192  Show
UniProt is an ELIXIR core data resource
Main funding by: National Institutes of Health

We'd like to inform you that we have updated our Privacy Notice to comply with Europe’s new General Data Protection Regulation (GDPR) that applies since 25 May 2018.

Do not show this banner again